Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Texas Health Center COVID-19 Survey Summary Report

Texas Health Center COVID-19 Survey Summary Report

Latest data from June 17, 2022

Number of Health Center respondents = 59 (82% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 7,009
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 80.87%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 1,305
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 79.18%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 17.78% 18.77%
White, Hispanic/Latino Patients 56.80% 54.02%
Black/African American, Non-Hispanic/Latino Patients 8.56% 7.66%
Black/African American, Hispanic/Latino Patients 0.56% 0.31%
Asian Patients3 1.68% 2.76%
American Indian/Alaska Native Patients3 0.29% 0.31%
Native Hawaiian/Other Pacific Islander Patients3 0.30% 0.31%
Patients with More Than One Race3 2.08% 1.38%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.88% 4.67%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.93% 1.53%
Unreported/Refused to Report Race and Ethnicity 6.15% 8.28%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 765
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 90.37%
COVID-19 Immunization Series Completed 699
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 92.27%
COVID-19 Immunization Series Additional 1,735
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 87.28%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 9.15% 7.44% 12.10%
White, Hispanic/Latino Patients 66.93% 71.10% 59.42%
Black/African American, Non-Hispanic/Latino Patients 8.76% 9.01% 8.24%
Black/African American, Hispanic/Latino Patients 0.92% 0.14% 0.17%
Asian Patients3 1.31% 1.43% 1.67%
American Indian/Alaska Native Patients3 0.13% 0.29% 2.48%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.14% 0.17%
Patients with More Than One Race3 0.92% 1.43% 0.40%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.93% 5.29% 10.49%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.65% 0.29% 0.58%
Unreported/Refused to Report Race and Ethnicity 4.31% 3.43% 4.27%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 40.68%
1 to 24 Hours 30.51%
More Than 24 Hours 27.12%
N/A 1.69%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 6.78%
Staffing to administer the vaccine 22.03%
Vaccine confidence 32.20%
Vaccine storage capacity 1.69%
Vaccine supply 1.69%
Other 5.08%
None 47.46%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 30.51%
Average Percent of Health Center Visits Conducted Virtually 11.27%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 22.03%
Number of Mobile Van Sites 9
Number of Pop-up Clinics 5
Number of School-Based Vaccination Sites 2
Number of Family Vaccination Clinics 36

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 1.69%
Refer patients to another organization that provides monoclonal antibody therapies 57.63%
None 40.68%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 16.95%
Patient awareness/education 5.08%
Staffing capacity 16.95%
Therapy administration/onsite logistics 23.73%
Other 6.78%
None 59.32%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 29
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 14,288

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 86.21%
Provided to General Public Who Came to the Health Center 41.38%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 24.14%
Provided at Other Community Events 24.14%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 10.34%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 27.59%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 17.24%
Provided to school-age children and/or their families directly or through partnerships with schools 24.14%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 13.79%
Other 0.00%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 19
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 22,122

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 89.47%
Provided to General Public Who Came to the Health Center 52.63%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 31.58%
Provided at Other Community Events 26.32%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 21.05%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 42.11%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 31.58%
Provided to school-age children and/or their families directly or through partnerships with schools 31.58%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 26.32%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 10
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 80.33%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 10.88%
White, Hispanic/Latino Patients 70.29%
Black/African American, Non-Hispanic/Latino Patients 2.93%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 2.51%
American Indian/Alaska Native Patients3 0.84%
Native Hawaiian/Other Pacific Islander Patients3 0.42%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.35%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.51%
Unreported/Refused to Report Race and Ethnicity 6.28%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 1.26%
Patients Experiencing Homelessness 2.51%
Patients Who Are Residents of Public Housing 2.51%
Patients with Limited English Proficiency 21.34%
Children Under 18 Years of Age 2.93%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: